Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Deferasirox

Drug-induced ileocolitis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fuentes-Valenzuela E, et al. Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis. Gastroenterologia y Hepatologia 47: 380-381, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1016/j.gastrohep.2023.07.002 Fuentes-Valenzuela E, et al. Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitis. Gastroenterologia y Hepatologia 47: 380-381, No. 4, Apr 2024. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​gastrohep.​2023.​07.​002
Metadaten
Titel
Deferasirox
Drug-induced ileocolitis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56797-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Testosterone

Case report

Dexamfetamine